Actinium Pharmaceuticals, Inc. Common Stock — 四半期キャッシュフロー (NYSE:ATNM) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 76.9 M68.65 M63.02 M56.15 M51.77 M45.44 M 負債合計 44.14 M42.95 M44 M42.37 M43.94 M43.13 M 純資産合計 32.76 M25.69 M19.01 M13.78 M7.83 M2.3 M 負債および純資産合計 76.9 M68.65 M63.02 M56.15 M51.77 M45.44 M 有利子負債合計 —————— 純負債 ——————

ニュース

Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year?

アクチニウム・ファーマシューティカルズ社の株価、有望な乳がん治療薬データを受け上昇

Actinium Pharmaceuticals stock rises after promising breast cancer therapy data

アクチニウムの乳がん治療薬が前臨床試験で有望な結果を示す

Actinium’s breast cancer therapy shows promise in preclinical studies

Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?

アクチニウムのATNM-400、耐性乳がんに有効性を示す

Actinium’s ATNM-400 shows efficacy in resistant breast cancers

アクチニウム・ファーマシューティカルズ、年次株主総会で取締役選任と提案を承認

Actinium Pharmaceuticals elects directors and approves proposals at annual meeting

Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?

Actinium’s ATNM-400 shows superior efficacy against lung cancer